Abbott Laboratories’ ABT Established Pharmaceuticals Division (“EPD”) operates solely in emerging geographies, with leading positions in many of the largest and fastest-growing pharmaceutical markets ...

Thanks to a series of equity and debt offerings, Insulet has managed to buy time in the race to expand its sales base and reach profitability before running out of cash. As of the end of December, ...

Some high-profile healthcare names are at even cheaper valuations. For example, Merck is trading at a forward P/E of 8.7, ...

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Abbott Laboratories is reshaping the investment landscape with its latest trading strategies. Mid-range consolidation at $130 ...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, ...

Abbott Laboratories is gearing up for a potentially lucrative market play. Mid-term corrections in a long-term uptrend are ...

However, state troopers may have limited ability to enforce Abbott's order. Under House rules, the Texas House can authorize ...

Texas Gov. Greg Abbott has launched a digital ad campaign against House Democrats who left the state to upend a Republican-driven redistricting bill.

Three Motley Fool contributors believe they've found such unstoppable stocks with the "it" factor to buy in August -- and ...

High-quality dividend stocks can provide superior returns and consistent passive income over the long term. The two companies below are leaders in their respective industries and boast attractive ...

Abbott Laboratories (NYSE:ABT) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty.